Charles River Laboratories
Nathan McCurdy, CPA, MBA, currently serves as Director of Finance at Charles River Laboratories since July 2021. Prior experience includes roles as Director of Finance at Myriad Genetics from March 2016 to July 2021 and as Plant Controller at ICU Medical from September 2014 to March 2016. Nathan began as a Senior Financial Analyst at Myriad Genetics and held similar positions at Dyno Nobel and Cephalon. Initial career experience includes serving as a Cost Accountant at Edwards Lifesciences and as an Airman in the Utah Air National Guard. Nathan holds a Bachelor's degree in Accounting from the University of Utah and an MBA in Accounting from Westminster University. Expertise encompasses variance analysis, budgeting, forecasting, fixed assets, COGS analysis, and balance sheet reconciliation.
This person is not in any teams
This person is not in any offices
Charles River Laboratories
16 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.